search
Back to results

Using NI-ES to Treat Spinal Cord Injury (SCI)

Primary Purpose

Spinal Cord Injuries, Pain, Neuropathic

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Alpha-Stim M
Sponsored by
SCI Research Advancement
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Cord Injuries focused on measuring Electrical Stimulation, Transcutaneous, Spinal Cord Injury, Neutrophic Pain, Functional Movements

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male or female
  • The presence of SCI
  • Pain associated with the SCI
  • Difficulty with body movement below the SCI

Exclusion Criteria:

  • Absence of SCI
  • Poor health
  • Deemed unsuitable for participation by the Investigator.

Sites / Locations

  • Home site

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Treatment

Arm Description

The treatment or intervention is the use of NI-ES using a signal generator, Alpha-Stim M, with an Ocular Interface connected to one channel and a Spinal Interface to the other channel. The treatment is done at home for 40 minutes at a time, twice a day. The upper lids of the closed eyes are treated for 10 minutes and the lower lids of the closed eyes are treated for 10 minutes, alternated throughout the treatment time. The Spinal Interface is placed above the SCI for 40 minutes. The entire procedure is repeated for another 40 minutes for a second time. The participant will treat himself at home.

Outcomes

Primary Outcome Measures

Pain reduction measured by Pain Questionnaire
Reduce neuropathic pain

Secondary Outcome Measures

Functional movement as measured by the ASIA Motor Score
Movement below the SCI

Full Information

First Posted
September 15, 2019
Last Updated
October 4, 2019
Sponsor
SCI Research Advancement
Collaborators
DuBois Vision Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT04097015
Brief Title
Using NI-ES to Treat Spinal Cord Injury (SCI)
Official Title
Using Non-Invasive Electrical Stimulation (NI-ES) to Treat Spinal Cord Injury (SCI)
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Unknown status
Study Start Date
September 20, 2019 (Actual)
Primary Completion Date
October 31, 2019 (Anticipated)
Study Completion Date
November 18, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
SCI Research Advancement
Collaborators
DuBois Vision Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
NI-ES therapy is a treatment that is being studied to potentially treat pain associated with SCI and may help movement below the injury site.
Detailed Description
The overall goal of this study is to assess the use of externally applied micro-current electrical stimulation in a subject with SCI to reduce pain and patient perceived improvement of quality of life first, and second, movement below the SCI injury. The Hypothesis is that NI-ES is beneficial in reducing pain following SCI injury, patient perceived quality of life measures, and functional outcomes. We plan to achieve this goal by conducting a Pain Questionnaire and assessment of movement below the injury site prior to external micro-current electrical stimulation with the Spinal Stim (Alpha-Stim M with the Ocular Interface and the Spinal Interface) and again six weeks following the first treatment. These results will be used to characterize the extent and duration of any improvement in pain and movement as a result of treatment with the Spinal Stim.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries, Pain, Neuropathic
Keywords
Electrical Stimulation, Transcutaneous, Spinal Cord Injury, Neutrophic Pain, Functional Movements

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
The intervention model is a single group assignment.
Masking
None (Open Label)
Allocation
N/A
Enrollment
1 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treatment
Arm Type
Experimental
Arm Description
The treatment or intervention is the use of NI-ES using a signal generator, Alpha-Stim M, with an Ocular Interface connected to one channel and a Spinal Interface to the other channel. The treatment is done at home for 40 minutes at a time, twice a day. The upper lids of the closed eyes are treated for 10 minutes and the lower lids of the closed eyes are treated for 10 minutes, alternated throughout the treatment time. The Spinal Interface is placed above the SCI for 40 minutes. The entire procedure is repeated for another 40 minutes for a second time. The participant will treat himself at home.
Intervention Type
Device
Intervention Name(s)
Alpha-Stim M
Intervention Description
Alpha-Stim M with and Ocular Interface and a Spinal Interface
Primary Outcome Measure Information:
Title
Pain reduction measured by Pain Questionnaire
Description
Reduce neuropathic pain
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Functional movement as measured by the ASIA Motor Score
Description
Movement below the SCI
Time Frame
6 weeks

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or female The presence of SCI Pain associated with the SCI Difficulty with body movement below the SCI Exclusion Criteria: Absence of SCI Poor health Deemed unsuitable for participation by the Investigator.
Facility Information:
Facility Name
Home site
City
Buellton
State/Province
California
ZIP/Postal Code
93427
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Using NI-ES to Treat Spinal Cord Injury (SCI)

We'll reach out to this number within 24 hrs